Resection and liver transplantation for HCC.

Journal of Gastroenterology
Jacques Belghiti

Abstract

About 10 years ago, several studies made it clear that liver transplantation (LT) for patients with chronic liver disease and limited hepatocellular carcinoma (HCC) without vascular invasion offers better long-term survival than resection alone. However, during the past 10 years, the persistent imbalance between the increasing numbers of candidates for LT and a limited organ supply has made it necessary to temper the enthusiasm for LT. Organ shortage necessarily results in prolonged waiting time. In turn, prolonged waiting time results in tumor growth with an increasing risk of vascular invasion, a source of post-LT recurrence. In parallel, advances in liver surgery have significantly improved the safety of resection. It has been shown that, in contrast to what could be expected, prior resection neither increases operative morbidity nor impairs survival following deceased donor transplantation. Resection can be used as a treatment for HCC before LT in three different settings. First, resection can be used as a primary therapy, with LT reserved as a "salvage" therapy for patients who develop recurrence or liver failure. Second, resection can be used as an initial therapy to select patients who might obtain benefit from LT accord...Continue Reading

References

Mar 14, 1996·The New England Journal of Medicine·V MazzaferroL Gennari
Aug 8, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F P SarasinA Hadengue
Jun 8, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F Y YaoJ P Roberts
Oct 3, 2002·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Francis Y YaoJohn P Roberts
Sep 23, 2003·Annals of Surgery·Charles H ChaRonald P DeMatteo
Nov 25, 2003·Annals of Surgery·Jacques BelghitiReza Kianmanesh
May 27, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Ronnie T Poon, Sheung Tat Fan
Sep 18, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Margarita SalaUNKNOWN Barcelona Clinic Liver Cancer (BCLC) Group
Jul 26, 2005·Annals of Surgery·Kiyoshi HasegawaMasatoshi Makuuchi
Sep 27, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Carlos MargaritItxarone Bilbao
Jan 16, 2007·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Yuichiro OtsukaRonald W Busuttil

❮ Previous
Next ❯

Citations

Sep 15, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Can-Liang LuYun-Fei Yuan
Dec 15, 2011·Polski przeglad chirurgiczny·Michał GrątMarek Krawczyk
Jul 26, 2013·World Journal of Gastroenterology : WJG·Jian-Yong LeiWen-Tao Wang
Feb 2, 2013·World Journal of Gastroenterology : WJG·Sung Hoon ChoiSoon Il Kim
Jan 24, 2014·International Journal of Hepatology·Roberto GaluppoRoberto Gedaly
Aug 1, 2015·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·John T MiuraT Clark Gamblin
Dec 8, 2009·Current Problems in Surgery·Charles H ChaSharon M Weber
Jan 29, 2014·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Edith Y HoUNKNOWN HOVAS Group (Hepatocellular Carcinoma Treatment Outcome at VA San Francisco)
Dec 15, 2012·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Josh Levitsky, Gabriel C Oniscu
May 3, 2012·ANZ Journal of Surgery·Georgios TsoulfasDimitrios Kiskinis
May 19, 2010·Transplant International : Official Journal of the European Society for Organ Transplantation·Shin HwangSung-Gyu Lee
Sep 26, 2015·Surgical Oncology·Gian Piero GuerriniMichele Colledan
Aug 15, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robbert J de HaasDaniel Azoulay
Dec 9, 2010·The Oncologist·Sheng-Long YeJean-Pierre Bronowicki
Nov 26, 2009·World Journal of Gastroenterology : WJG·Sudeep TanwarAshley Brown
Jun 9, 2015·World Journal of Hepatology·Ayman Zaki Azzam
Dec 6, 2017·Indian Journal of Surgical Oncology·Ahhmed SenbelAdel Denwer
May 20, 2021·Journal of Clinical and Translational Hepatology·Leana Frankul, Catherine Frenette

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Hepatology
Carlos Rodríguez de LopeJ Bruix
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
Robin D Kim, Alan W Hemming
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Josep M LlovetJ Bruix
© 2021 Meta ULC. All rights reserved